These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1096799)

  • 41. Relation of cell wall lipid content of Serratia marcescens to resistance to antimicrobial agents.
    Winshell EB; Neu HC
    Antimicrob Agents Chemother; 1974 Jul; 6(1):73-5. PubMed ID: 15828173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.
    Tsou MF; Yu WL; Hung SW; Chi CJ; Chieh-Ju ; Chen SC; Wu LT
    Folia Microbiol (Praha); 2004; 49(4):452-6. PubMed ID: 15530012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. R factor-mediated antibiotic resistance in Serratia marcescens.
    Cooksey RC; Thorne GM; Farrar WE
    Antimicrob Agents Chemother; 1976 Jul; 10(1):123-7. PubMed ID: 791085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antimicrobial activities of gentamicin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T
    Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens.
    Sirisanthana T; Lerner SA
    Antimicrob Agents Chemother; 1979 Apr; 15(4):630-2. PubMed ID: 380465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.
    Okuda T; Endo N; Osada Y; Zen-Yoji H
    J Clin Microbiol; 1984 Oct; 20(4):691-5. PubMed ID: 6386875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens.
    Yu VL; Oakes CA; Axnick KJ; Merigan TC
    Am J Med; 1979 Mar; 66(3):468-72. PubMed ID: 373434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of The Pathogenic Potential of Insecticidal
    Konecka E; Mokracka J; Krzymińska S; Kaznowski A
    Pol J Microbiol; 2019; 68(2):185-191. PubMed ID: 31257791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serratia: opportunistic pathogen of increasing clinical importance.
    Kwitko AO; Hamra LK; Atkinson JM
    Med J Aust; 1977 Jul; 2(4):119-21. PubMed ID: 331049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance.
    Chen J; Lee EW; Kuroda T; Mizushima T; Tsuchiya T
    Biol Pharm Bull; 2003 Mar; 26(3):391-3. PubMed ID: 12612456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of Serratia species in clinical specimens.
    Johnson E; Ellner PD
    Appl Microbiol; 1974 Sep; 28(3):513-4. PubMed ID: 4609016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous outbreaks of infection due to Serratia marcescens in a general hospital.
    Coleman D; Falkiner FR; Carr ME; Dowd G; Dougan G; Keane CT
    J Hosp Infect; 1984 Sep; 5(3):270-82. PubMed ID: 6208246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.